2020 Q3 Form 10-Q Financial Statement

#000156459020048948 Filed on October 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q3
Revenue $5.645B $5.381B $5.925B
YoY Change -4.72% -5.82% 12.62%
Cost Of Revenue $4.565B $4.400B $4.687B
YoY Change -2.62% -1.04% 14.36%
Gross Profit $1.081B $981.8M $1.238B
YoY Change -12.7% -22.58% 6.52%
Gross Profit Margin 19.14% 18.25% 20.89%
Selling, General & Admin $794.2M $740.6M $814.4M
YoY Change -2.48% -15.96% -5.2%
% of Gross Profit 73.5% 75.43% 65.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $127.7M $116.4M $111.6M
YoY Change 14.43% 9.3% -1.59%
% of Gross Profit 11.82% 11.86% 9.02%
Operating Expenses $921.9M $857.0M $932.6M
YoY Change -1.15% -2.32% -4.1%
Operating Profit $211.4M $94.17M $316.6M
YoY Change -33.23% -66.89% 66.9%
Interest Expense $14.50M $1.500M $4.000M
YoY Change 262.5% -153.57% -96.06%
% of Operating Profit 6.86% 1.59% 1.26%
Other Income/Expense, Net $7.947M $5.220M $941.0K
YoY Change 744.53% 19.48% -99.01%
Pretax Income $233.9M $100.9M $321.5M
YoY Change -27.25% -64.71% -16.84%
Income Tax $49.06M $18.80M $63.47M
% Of Pretax Income 20.98% 18.63% 19.74%
Net Earnings $184.1M $81.90M $256.6M
YoY Change -28.24% -63.39% -11.66%
Net Earnings / Revenue 3.26% 1.52% 4.33%
Basic Earnings Per Share $0.55 $0.24 $0.76
Diluted Earnings Per Share $0.55 $0.24 $0.75
COMMON SHARES
Basic Shares Outstanding 335.3M shares 335.1M shares 336.2M shares
Diluted Shares Outstanding 337.7M shares 337.4M shares 341.1M shares

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.482B $1.214B $577.0M
YoY Change 156.85% 126.49% 4.91%
Cash & Equivalents $1.647B $1.314B $577.5M
Short-Term Investments
Other Short-Term Assets $735.0M $684.0M $264.3M
YoY Change 178.12% 187.64% -56.25%
Inventory
Prepaid Expenses $284.9M $282.6M
Receivables $4.280B $4.424B $4.058B
Other Receivables $1.275B $868.0M $1.027B
Total Short-Term Assets $7.771B $7.189B $7.059B
YoY Change 10.09% 4.41% 10.67%
LONG-TERM ASSETS
Property, Plant & Equipment $1.976B $1.986B $782.0M
YoY Change 152.68% 166.05% 11.4%
Goodwill $3.627B
YoY Change
Intangibles $1.326B
YoY Change
Long-Term Investments $393.0M $386.0M $329.0M
YoY Change 19.45% 25.61% 68.72%
Other Assets $911.0M $888.0M $795.3M
YoY Change 14.54% 17.96% 21.61%
Total Long-Term Assets $8.576B $8.511B $7.982B
YoY Change 7.44% 8.64% 20.96%
TOTAL ASSETS
Total Short-Term Assets $7.771B $7.189B $7.059B
Total Long-Term Assets $8.576B $8.511B $7.982B
Total Assets $16.35B $15.70B $15.04B
YoY Change 8.68% 6.66% 15.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.429B $2.329B $2.085B
YoY Change 16.5% 12.84% 24.55%
Accrued Expenses $2.221B $1.932B $2.263B
YoY Change -1.86% -1.68% 19.23%
Deferred Revenue $132.5M $128.4M $110.9M
YoY Change 19.47% 17.25% 27.82%
Short-Term Debt $1.197B $1.210B $1.405B
YoY Change -14.78% -23.42% -18.38%
Long-Term Debt Due $1.526M $1.540M $1.897M
YoY Change -19.56% -31.8% -52.58%
Total Short-Term Liabilities $6.152B $5.853B $6.028B
YoY Change 2.06% -0.59% 9.88%
LONG-TERM LIABILITIES
Long-Term Debt $1.783B $1.763B $1.748B
YoY Change 2.0% -0.2% -0.67%
Other Long-Term Liabilities $1.683B $1.664B $436.7M
YoY Change 285.36% 271.61% -30.92%
Total Long-Term Liabilities $1.783B $1.763B $2.185B
YoY Change -18.39% -20.38% 245.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.152B $5.853B $6.028B
Total Long-Term Liabilities $1.783B $1.763B $2.185B
Total Liabilities $9.794B $9.456B $9.482B
YoY Change 3.29% 1.37% 15.57%
SHAREHOLDERS EQUITY
Retained Earnings $5.156B
YoY Change 25.41%
Common Stock $1.143B
YoY Change -10.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.553B $6.244B $5.512B
YoY Change
Total Liabilities & Shareholders Equity $16.35B $15.70B $15.04B
YoY Change 8.68% 6.66% 15.9%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q3
OPERATING ACTIVITIES
Net Income $184.1M $81.90M $256.6M
YoY Change -28.24% -63.39% -11.66%
Depreciation, Depletion And Amortization $127.7M $116.4M $111.6M
YoY Change 14.43% 9.3% -1.59%
Cash From Operating Activities $854.5M $134.9M $468.0M
YoY Change 82.59% 35.85% -21.27%
INVESTING ACTIVITIES
Capital Expenditures -$56.40M -$71.90M -$71.80M
YoY Change -21.45% 6.99% 61.71%
Acquisitions
YoY Change
Other Investing Activities -$14.10M $28.20M -$51.80M
YoY Change -72.78% -508.7% 56.97%
Cash From Investing Activities -$70.60M -$43.70M -$123.6M
YoY Change -42.88% -41.11% 59.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -488.3M 478.4M -238.0M
YoY Change 105.17% -519.65% -50.36%
NET CHANGE
Cash From Operating Activities 854.5M 134.9M 468.0M
Cash From Investing Activities -70.60M -43.70M -123.6M
Cash From Financing Activities -488.3M 478.4M -238.0M
Net Change In Cash 295.6M 569.6M 106.4M
YoY Change 177.82% -740.72% 184.49%
FREE CASH FLOW
Cash From Operating Activities $854.5M $134.9M $468.0M
Capital Expenditures -$56.40M -$71.90M -$71.80M
Free Cash Flow $910.9M $206.8M $539.8M
YoY Change 68.75% 24.2% -15.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2019Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2020Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2019Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
284947000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
282741000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
73864000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
34593000
CY2020Q3 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
228038000
CY2019Q4 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
185508000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
95380000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
89037000
CY2019Q3 cbre Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets
CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets
5608480000
CY2019Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
9000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
19266000
us-gaap Revenues
Revenues
16915694000
us-gaap Revenues
Revenues
16774684000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
4687336000
us-gaap Cost Of Revenue
CostOfRevenue
13676790000
us-gaap Cost Of Revenue
CostOfRevenue
13155160000
CY2019Q3 cbre Operating Administrative And Other Expenses
OperatingAdministrativeAndOtherExpenses
809584000
cbre Operating Administrative And Other Expenses
OperatingAdministrativeAndOtherExpenses
2355099000
cbre Operating Administrative And Other Expenses
OperatingAdministrativeAndOtherExpenses
2479857000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
357903000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
323862000
cbre Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets
CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets
16464963000
cbre Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets
CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets
16047916000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
75132000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
321521000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40237000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-320000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-51795000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-67638000
us-gaap Operating Income Loss
OperatingIncomeLoss
525863000
us-gaap Operating Income Loss
OperatingIncomeLoss
746034000
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
25796000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
72487000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
120233000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
941000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12974000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26163000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21846000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
559529000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
822184000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63468000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
119047000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169867000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
258053000
us-gaap Profit Loss
ProfitLoss
440482000
us-gaap Profit Loss
ProfitLoss
652317000
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1454000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2258000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7578000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
256599000
us-gaap Net Income Loss
NetIncomeLoss
438224000
us-gaap Net Income Loss
NetIncomeLoss
644739000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.92
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336203747
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335128531
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336149719
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.89
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
341100182
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
338255859
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
340590007
CY2019Q3 us-gaap Profit Loss
ProfitLoss
258053000
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
45333000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-104000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
881000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1311000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2341000
cbre Increase Decrease In Real Estate Under Development
IncreaseDecreaseInRealEstateUnderDevelopment
3356000
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-13045000
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
7378000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-69535000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-51651000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-68945000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
188518000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
388831000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
583372000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1340000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2258000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7445000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
187178000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
386573000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
575927000
us-gaap Profit Loss
ProfitLoss
652317000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
323862000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7196000
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
191103000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
89037000
us-gaap Gain Loss On Investments
GainLossOnInvestments
26163000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
18083000
cbre Increase Decrease In Warehouse Lines Of Credit
IncreaseDecreaseInWarehouseLinesOfCredit
19849000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-28617000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-18367000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
300000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
835671000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2683000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
835671000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-128693000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
158708000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-550932000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-194592000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-118736000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
132583000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
12313000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
36793000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
860642000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
174749000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
190546000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
196031000
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
25923000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
72058000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
84648000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
66409000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
20960000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-15631000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2864000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-206487000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-271699000
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
300000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2631000000
cbre Proceeds From Notes Payable On Real Estate
ProceedsFromNotesPayableOnRealEstate
40263000
cbre Proceeds From Notes Payable On Real Estate
ProceedsFromNotesPayableOnRealEstate
5243000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50028000
cbre Proceeds From Payments Of Merger Related Costs Financing Activities
ProceedsFromPaymentsOfMergerRelatedCostsFinancingActivities
-36089000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1977000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
2471000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-334000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-111324000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9981000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
552812000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1646557000
us-gaap Interest Paid Net
InterestPaidNet
60415000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
811000
us-gaap Net Income Loss
NetIncomeLoss
438224000
us-gaap Net Income Loss
NetIncomeLoss
644739000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336203747
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335128531
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336149719
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
71892000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
4564579000
CY2020Q3 cbre Operating Administrative And Other Expenses
OperatingAdministrativeAndOtherExpenses
794227000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
127725000
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111560000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
75171000
CY2020Q3 cbre Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets
CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets
5486531000
CY2020Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
52797000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
211408000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
316630000
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
32376000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7947000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17829000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2608000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
233902000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49062000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
184840000
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
708000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
184132000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335287245
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
337665848
CY2020Q3 us-gaap Profit Loss
ProfitLoss
184840000
us-gaap Profit Loss
ProfitLoss
440482000
us-gaap Profit Loss
ProfitLoss
652317000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
106201000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-78177000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-79772000
CY2020Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-106000
CY2019Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-377000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1212000
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
7000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
811000
CY2019Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
7377000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
107118000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
291958000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
708000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
291250000
us-gaap Profit Loss
ProfitLoss
440482000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
357903000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4632000
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
179506000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
75171000
us-gaap Gain Loss On Investments
GainLossOnInvestments
12974000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
49498000
cbre Share Based Compensation Reversal And Expense
ShareBasedCompensationReversalAndExpense
-41841000
cbre Share Based Compensation Reversal And Expense
ShareBasedCompensationReversalAndExpense
-98958000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
120233000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
11727227000
cbre Increase Decrease In Warehouse Lines Of Credit
IncreaseDecreaseInWarehouseLinesOfCredit
214659000
cbre Increase Decrease In Advance Warehouse Funding
IncreaseDecreaseInAdvanceWarehouseFunding
376707000
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
8932000
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
81369000
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
11210000
cbre Increase Decrease In Real Estate Under Development
IncreaseDecreaseInRealEstateUnderDevelopment
68178000
cbre Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets
IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets
-610058000
cbre Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets
IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets
644586000
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
14844000
cbre Repayment Of Notes Payable On Real Estate
RepaymentOfNotesPayableOnRealEstate
24704000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
94088000
cbre Proceeds From Payments Of Merger Related Costs Financing Activities
ProceedsFromPaymentsOfMergerRelatedCostsFinancingActivities
-34400000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
41627000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16573000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
46513000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3798000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5171000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-51963000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-12726000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-161639000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
702305000
us-gaap Interest Paid Net
InterestPaidNet
80179000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4137000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
302735000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6285051000
CY2020Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-255000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
184840000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22137000
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4269000
CY2020Q3 cbre Minority Interest Increase From Contributions From Noncontrolling Interest Holders
MinorityInterestIncreaseFromContributionsFromNoncontrollingInterestHolders
549000
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1379000
cbre Minority Interest Increase From Contributions From Noncontrolling Interest Holders
MinorityInterestIncreaseFromContributionsFromNoncontrollingInterestHolders
1977000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2471000
us-gaap Stockholders Equity Other
StockholdersEquityOther
30378000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6594302000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5009902000
us-gaap Profit Loss
ProfitLoss
652317000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
98958000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
16573000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6594302000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5390530000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
258053000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33378000
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7008000
CY2019Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
49000000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-78177000
CY2019Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-377000
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
7000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
881000
CY2019Q3 cbre Minority Interest Increase From Contributions From Noncontrolling Interest Holders
MinorityInterestIncreaseFromContributionsFromNoncontrollingInterestHolders
4536000
CY2019Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1235000
CY2019Q3 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
26000
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5558980000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6273112000
us-gaap Profit Loss
ProfitLoss
440482000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41841000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
41627000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
50028000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40237000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-320000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1311000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
94088000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-79772000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1212000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-104000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2341000
cbre Minority Interest Increase From Contributions From Noncontrolling Interest Holders
MinorityInterestIncreaseFromContributionsFromNoncontrollingInterestHolders
46513000
us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
67667000
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5558980000
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:0pt;text-align:justify;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td> <td valign="top"> <p style="margin-top:0pt;text-align:justify;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-weight:normal;"/>Basis of Presentation</p></td></tr></table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Readers of this Quarterly Report on Form 10-Q (Quarterly Report) should refer to the audited financial statements and notes to consolidated financial statements of CBRE Group, Inc., a Delaware corporation (which may be referred to in these financial statements as “the company,” “we,” “us” and “our”), for the year ended December 31, 2019, which are included in our <a href="http://www.sec.gov/Archives/edgar/data/1138118/000156459020008056/cbre-10k_20191231.htm"><span style="text-decoration:underline;">2019 Annual Report on Form 10-K (2019 Annual Report),</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> filed with the United States Securities and Exchange Commission (SEC) and also available on our website (www.cbre.com), since we have omitted from this Quarterly Report certain footnote disclosures which would substantially duplicate those contained in such audited financial statements. You should also refer to Note 2, Significant Accounting Policies, in the notes to consolidated financial statements in our 2019 Annual Report for further discussion of our significant accounting policies and estimates.</span></p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Considerations Related to the COVID‑19 Pandemic</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The outbreak of the novel coronavirus (COVID‑19) global pandemic in the first quarter of 2020 has created a tremendous amount of uncertainty, precipitated a global economic contraction and severely disrupted both business activity and global real estate markets.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From 2010 to early 2020, commercial real estate markets had generally been characterized by increased demand for space, falling vacancies, higher rents and strong capital flows, leading to solid property sales and leasing activity. This healthy backdrop changed abruptly in the first quarter of 2020 with the emergence of the COVID‑19 pandemic and resultant sharp contraction of economic activity across much of the world. There has been a significant impact on commercial real estate markets, as many property owners and occupiers have put transactions on hold and withdrawn existing mandates, sharply reducing sales and leasing volumes. We expect to see this trend continue, as concerns about a COVID-19 resurgence are high across our major markets. The recovery of real estate markets around the world remained uncertain as of October 2020. </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect the effects of COVID‑19 will adversely impact our financial position, results of operations, and cash flows for fiscal year 2020. The unaudited consolidated financial statements presented herein reflect our current estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures as of the date of the financial statements and reported amounts of sales and expenses during the reporting periods presented.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 6 (Fair Value Measurements) and Note 10 (Commitments and Contingencies) for further discussion of COVID‑19 considerations.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Financial Statement Preparation</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared in accordance with the rules applicable to quarterly reports on Form 10-Q and include all information and footnotes required for interim financial statement presentation, but do not include all disclosures required under accounting principles generally accepted in the United States (U.S.), or GAAP, for annual financial statements. In our opinion, all adjustments (consisting of normal recurring adjustments, except as otherwise noted) considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions about future events, including the impact COVID‑19 may have on our business. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported and reported amounts of revenue and expenses. Such estimates include the value of goodwill, intangibles and other long-lived assets, real estate assets, accounts receivable, contract assets, operating lease assets, investments in unconsolidated subsidiaries and assumptions used in the calculation of income taxes, retirement and other post-employment benefits, among others. These estimates and assumptions are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain re</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">classifications</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> have been made to the 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> financial statements to conform with the 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> presentation</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:2pt;text-align:justify;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td> <td valign="top"> <p style="margin-top:2pt;text-align:justify;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">New Accounting Pronouncements      </p></td></tr></table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements Pending Adoption</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018‑14, “<span style="font-style:italic;">Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans.</span>” This ASU makes minor changes to the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. This ASU is effective for fiscal years ending after December 15, 2020, with early adoption permitted. ASU 2018-14 only revises disclosure requirements. We are evaluating the effect, if any, that ASU 2018‑14 will have on our disclosures, but do not expect it to have a material impact.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued ASU 2019‑12, “<span style="font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.</span>” This ASU removes specific exceptions to the general principles in Topic 740 and improves and simplifies financial statement preparers’ application of income tax-related guidance. This ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those years, with early adoption permitted. We are evaluating the effect that ASU 2019‑12 will have on our consolidated financial statements and related disclosures, but do not expect it to have a material impact.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2020, the FASB issued ASU 2020‑01, “<span style="font-style:italic;">Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).</span>” This ASU, among other things, clarifies that a company should consider observable transactions that require a company to either apply or discontinue the equity method of accounting under Topic 323 and clarifies that, when determining the accounting for certain forward contracts and purchased options a company should not consider, whether upon settlement or exercise, if the underlying securities would be accounted for under the equity method or fair value option. This ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those years, with early adoption permitted. We are evaluating the effect that ASU 2020‑01 will have on our consolidated financial statements and related disclosures.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the FASB issued ASU 2020‑04, “<span style="font-style:italic;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.”</span> This ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. This ASU is effective for a limited time for all entities through December 31, 2022. We are evaluating the effect that ASU 2020‑04 will have on our consolidated financial statements and related disclosures.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p>
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
89000000.0
CY2019Q4 cbre Loan Receivable Mortgage Warehouse Lending Current
LoanReceivableMortgageWarehouseLendingCurrent
993058000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
11727227000
us-gaap Gain Loss On Sales Of Mortgage Backed Securities Mbs
GainLossOnSalesOfMortgageBackedSecuritiesMBS
51380000
cbre Sale Of Mortgage Loans Held For Sale
SaleOfMortgageLoansHeldForSale
11513901000
us-gaap Proceeds From Collection Of Mortgage Loans Held For Sale
ProceedsFromCollectionOfMortgageLoansHeldForSale
51380000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
11565281000
cbre Net Increase Decrease In Mortgage Servicing Rights Included In Warehouse Receivables
NetIncreaseDecreaseInMortgageServicingRightsIncludedInWarehouseReceivables
5502000
CY2020Q3 cbre Loan Receivable Mortgage Warehouse Lending Current
LoanReceivableMortgageWarehouseLendingCurrent
1211886000
CY2020Q3 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue
59000000.0
CY2019Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue
45200000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1793692000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1773396000
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1526000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1814000
CY2020Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
8954000
CY2019Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
10337000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1783212000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1761245000
cbre Minimum Coverage Ratio Of Earnings Before Interest Tax Depreciation And Amortization To Interest Expense Expressed In Percentage
MinimumCoverageRatioOfEarningsBeforeInterestTaxDepreciationAndAmortizationToInterestExpenseExpressedInPercentage
2.00
cbre Maximum Leverage Ratio Of Debt To Earnings Before Interest Tax Depreciation And Amortization Expressed In Percentage
MaximumLeverageRatioOfDebtToEarningsBeforeInterestTaxDepreciationAndAmortizationExpressedInPercentage
4.25
cbre Maximum Leverage Ratio During First Four Quarter That Qualified Acquisition Is Consummated
MaximumLeverageRatioDuringFirstFourQuarterThatQualifiedAcquisitionIsConsummated
4.75
CY2020Q3 cbre Coverage Ratio Of Earnings Before Interest Tax Depreciation And Amortization To Interest Expense Expressed In Percentage
CoverageRatioOfEarningsBeforeInterestTaxDepreciationAndAmortizationToInterestExpenseExpressedInPercentage
23.68
CY2020Q3 cbre Leverage Ratio Of Debt To Earnings Before Interest Tax Depreciation And Amortization Expressed In Percentage
LeverageRatioOfDebtToEarningsBeforeInterestTaxDepreciationAndAmortizationExpressedInPercentage
0.25
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1057992000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
997966000
CY2020Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
99990000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
94141000
CY2020Q3 cbre Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
1157982000
CY2019Q4 cbre Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
1092107000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
189641000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
168663000
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
37780000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
34966000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1125005000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1057758000
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
62331000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
60001000
CY2020Q3 cbre Operating And Financing Lease Liability
OperatingAndFinancingLeaseLiability
1414757000
CY2019Q4 cbre Operating And Financing Lease Liability
OperatingAndFinancingLeaseLiability
1321388000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
175909000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
149259000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
34169000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
40819000
cbre Other Noncash Increases Decreases In Operating Lease Right Of Use Assets
OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets
6729000
cbre Other Noncash Increases Decreases In Operating Lease Right Of Use Assets
OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets
35510000
cbre Other Noncash Increases Decreases In Finance Lease Right Of Use Assets
OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets
-471000
cbre Other Noncash Increases Decreases In Finance Lease Right Of Use Assets
OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets
-1011000
CY2020Q3 cbre Loan Loss Sharing Reserve
LoanLossSharingReserve
56500000
CY2019Q4 cbre Loan Loss Sharing Reserve
LoanLossSharingReserve
37000000.0
CY2020Q3 cbre Assets Available For Recourse
AssetsAvailableForRecourse
928000000.0
CY2020Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
104400000
CY2020Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
104400000
cbre Line Of Credit Facility Latest Expiration Date
LineOfCreditFacilityLatestExpirationDate
2021-10
CY2020Q3 cbre Guarantor Obligations Maximum Exposure Undiscounted
GuarantorObligationsMaximumExposureUndiscounted
72400000
CY2020Q3 cbre Guarantor Obligations Maximum Exposure Undiscounted
GuarantorObligationsMaximumExposureUndiscounted
72400000
CY2020Q3 cbre Commitments To Investment In Future Real Estate Investment
CommitmentsToInvestmentInFutureRealEstateInvestment
84000000.0
CY2020Q3 cbre Commitments To Investment In Unconsolidated Entity
CommitmentsToInvestmentInUnconsolidatedEntity
41000000.0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49100000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63500000
CY2020Q3 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-14400000
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
119000000.0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169900000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-50900000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.213
us-gaap Net Income Loss
NetIncomeLoss
438224000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.207
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
142200000
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1000000.0
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1000000.0
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
6400000
CY2020Q3 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
5400000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
184132000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
256599000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335287245
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.92
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
184132000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
256599000
us-gaap Net Income Loss
NetIncomeLoss
644739000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335287245
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336203747
CY2020Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
157966000
CY2020Q3 us-gaap Revenues
Revenues
5645142000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5760025000
CY2019Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
165076000
CY2019Q3 us-gaap Revenues
Revenues
5925101000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16484546000
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
431148000
us-gaap Revenues
Revenues
16915694000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16322726000
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
451958000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335128531
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336149719
CY2020Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
2378603
CY2019Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4896435
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3127328
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4440288
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
337665848
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
341100182
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
338255859
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
340590007
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.89
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
350000000.0
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5487176000
us-gaap Revenues
Revenues
16774684000
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
459800000
CY2020Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
282000000.0
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
529800000
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
328000000.0
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
134300000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
132500000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
115000000.0
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
108700000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
77900000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2020Q3 us-gaap Revenues
Revenues
5645142000
CY2019Q3 us-gaap Revenues
Revenues
5925101000
us-gaap Revenues
Revenues
16915694000
CY2020Q3 cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
441764000
CY2019Q3 cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
454630000
cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
1139419000
cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
1373154000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
184132000
cbre Carried Interest Incentive Compensation Expense Reversal
CarriedInterestIncentiveCompensationExpenseReversal
12284000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
256599000
us-gaap Net Income Loss
NetIncomeLoss
438224000
us-gaap Net Income Loss
NetIncomeLoss
644739000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
127725000
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111560000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
357903000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
323862000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
75171000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
89037000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17829000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21846000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-51795000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-67638000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2608000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49062000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63468000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
119047000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169867000
CY2020Q3 cbre Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
378748000
CY2019Q3 cbre Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
453473000
cbre Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
1042140000
cbre Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
1297751000
CY2020Q3 cbre Costs Associated With Transformation Initiatives
CostsAssociatedWithTransformationInitiatives
55374000
cbre Costs Associated With Transformation Initiatives
CostsAssociatedWithTransformationInitiatives
55374000
CY2020Q3 cbre Carried Interest Incentive Compensation Expense Reversal
CarriedInterestIncentiveCompensationExpenseReversal
3767000
CY2019Q3 cbre Carried Interest Incentive Compensation Expense Reversal
CarriedInterestIncentiveCompensationExpenseReversal
-3360000
cbre Carried Interest Incentive Compensation Expense Reversal
CarriedInterestIncentiveCompensationExpenseReversal
-11517000
CY2020Q3 cbre Impact Of Fair Value Adjustments To Assets Acquired In Business
ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness
2289000
cbre Impact Of Fair Value Adjustments To Assets Acquired In Business
ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness
9289000
CY2020Q3 us-gaap Restructuring Costs
RestructuringCosts
1061000
us-gaap Restructuring Costs
RestructuringCosts
4995000
CY2020Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
525000
CY2019Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
4517000
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
1544000
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
13554000
cbre Costs Primarily Associated With Workforce Optimization Efforts
CostsPrimarilyAssociatedWithWorkforceOptimizationEfforts
37594000
us-gaap Restructuring Charges
RestructuringCharges
49565000
CY2020Q3 cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
441764000
CY2019Q3 cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
454630000
cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
1139419000
cbre Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
1373154000
CY2020Q3 us-gaap Revenues
Revenues
5645142000
CY2019Q3 us-gaap Revenues
Revenues
5925101000
us-gaap Revenues
Revenues
16915694000
us-gaap Revenues
Revenues
16774684000
CY2020Q3 cbre Costs Associated With Transformation Initiatives
CostsAssociatedWithTransformationInitiatives
55400000
cbre Costs Associated With Transformation Initiatives
CostsAssociatedWithTransformationInitiatives
55400000

Files In Submission

Name View Source Status
0001564590-20-048948-index-headers.html Edgar Link pending
0001564590-20-048948-index.html Edgar Link pending
0001564590-20-048948.txt Edgar Link pending
0001564590-20-048948-xbrl.zip Edgar Link pending
cbre-10q_20200930.htm Edgar Link pending
cbre-10q_20200930_htm.xml Edgar Link completed
cbre-20200930.xsd Edgar Link pending
cbre-20200930_cal.xml Edgar Link unprocessable
cbre-20200930_def.xml Edgar Link unprocessable
cbre-20200930_lab.xml Edgar Link unprocessable
cbre-20200930_pre.xml Edgar Link unprocessable
cbre-ex101_323.htm Edgar Link pending
cbre-ex221_7.htm Edgar Link pending
cbre-ex311_9.htm Edgar Link pending
cbre-ex312_6.htm Edgar Link pending
cbre-ex32_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gcrsdtzmy1yk000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending